Key result
Anticoagulation for stroke prevention in elderly AF patients faces eligibility limits rather than safety concerns.
Key points are not available for this paper at this time.
Design
Other
No takes yet. Share an insight, caveat, or question.
GI symptoms were associated with diabetes and poor control in this survey; leaves open whether optimizing glycemia reduces symptoms in prospective studies.
Giuseppe Bellelli (2002) studied this question. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation is limited primarily by patient eligibility rather than safety concerns.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: